{"nct_id":"NCT06517433","title":"First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2017-12-12","start_date_type":"ACTUAL","primary_completion_date":"2021-07-09","primary_completion_date_type":"ACTUAL","completion_date":"2021-07-09","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRSN"]}